by one-compartment analysis cannot be theoretically justified and therefore should be avoided.
INTRODUCTION
The classical linear pharmacokinetic models have been successfully used to accurately describe rates of absorption, metabolism., and excretion when applied to certain specific drugs and have been very useful for predictive purposes. During the past decade, many reports have provided evidence that linear systems of differential equations do not accurately describe the pharmacokinetic behavior of many compounds. Nonlinear pharmacokinetics to date are based on the Michaelis-Menten and Langmuir tissue-binding equations. Several authors (1) (2) (3) (4) have successfully used nonlinear pharmacokinetic models involving Michaelis-Menten equations to describe drug concentration-time data. However, these authors obtained val'aes for the constants, V,, and Kin, either from separate experiments (e.g., from in vitro studies) or by fitting data directly to the one-compartment open model with Michaelis-Menten elimination. Many of the methods used to indirectly evaluate enzyme constants in animals cannot be used in human beings. In addition, other authors (5) (6) have shown that in vitro enzyme constants are markedly dependent on experimental conditions. This sensitivity can introduce a large amount of uncertainty into the values of enzyme constants obtained from in vitro studies because in vitro enzyme environment may not accurately simulate conditions existing in vivo.
Direct pharmacokinetic estimation of enzyme constants avoids the problems above, but, as will be demonstrated, correct evaluation of these constants requires the use of an appropriate pharmacokinetic model.
Dedrick and Forrester (7) discussed the errors introduced into the values of V,, and Km when data described by a special form of, the twocompartment model were analyzed according to the one-compartment open model.
Wagner and Patel (3) used the one-compartment open model to analyze enzyme constants describing ethanol metabolism in man. Their data indicate the presence of a distribution phase, which is particularly evident after the administration of 60 ml of 95% ethanol. This suggests that a two-compartment model involving Michaelis-Menten elimination may prove to be a more accurate representation of pharmacokinetics of ethanol in man, and the remarks made by Dedrick and Forrester may apply. Therefore, the recognition of data described by multicompartment models and the consequences of analyzing such data by use of the onecompartment model are of considerable interest and importance.
The purposes of this paper are:
1. To discuss some of the properties of the two-compartment open model with Michaelis-Menten elimination. 2. To demonstrate the effects of fitting data which were generated with the equations of a two-compartment model involving Michaelis-Menten elimination kinetics by using the equations of a one-compartment model with Michaelis-Menten elimination kinetics. 
THEORY
where Co is the dOse of drug/volume of compartment 1 (mg/mI), C1 is the concentration of drug in compartment 1 (mg/ml), Cz is the amount of drug in compartment 2/volume of compartment 1 (mg/ml), t is time (hr), ka is the first-order absorption rate constant (hr-~), kaz is the first-order distribution rate constant from compartment 1 to compartment 2 (hr-a), k21 is the first-order distribution rate constant from compartment 2 to compartment 1 (hr-1), V,, is the maximum reaction rate [mg/(ml)(hr)], and K,, is the Michaelis constant (mg/ml).
A one-compartment model with Michaelis-Menten elimination is shown in scheme 2:
The model is mathematically described by dCa _ V,, " Ca (3) dt Km+ Ca where the symbols are defined as above.
These equations can be used to obtain values of C~ and/or Cz as a function of time by numerical integration. They also may be used in a similar manner to fit drug concentration-time data by means of a nonlinear least-squares estimation program and a high-speed digital computer.
EXPERIMENTAL

Generation of Simulated C,t Data
Simulated C,t data obeying equations 1 and 2 were generated by assigning numerical values to Co, k,, k12, k21, Vm, and Km using the program NONLIN and an IBM 360/67 computer. Equations 1 and 2 were numerically integrated by the computer using the Runge-Kutta method, which is a part of the program NONLIN. The simulations were performed with Vm = 0.418; Km= 0.182; k12 = 3; k21 = 2; k,= 8, 4, 2, 1, and 0.5; Co = 3, 2, and 0.5.
Fitting of Simulated C,t Data
The terminal portions of all of the sets of simulated data were fitted to the one-component open model with Michaelis-Menten elimination kinetics (scheme 2) by utilizing a linear transformation of equation 3. This technique is discussed in the Appendix. The constants for one set of data (ka = 8 and Co = 2) were also evaluated by two additional means: (a) a Lineweaver-Burk plot (8) of the terminal data and (b) nonlinear leastsquares computer fitting of the terminal data to equation 3.
RESULTS AND DISCUSSION
Some of the C,t data generated as described in the Experimental section are plotted on cartesian coordinate graphs in Figs. 1 and 2. These curves are characterized by an early distribution phase (a "nose" evident at the higher doses) followed by a pseudolinear region, then terminating in a curved portion. The presence of the distribution phase, indicated by the steeper slope of the blood concentration curve just past the peak, becomes increasingly apparent as the absorption rate and/or the dose of drug are raised. The slope of the subsequent pseudolinear phase (ko) is markedly dependent on both the absorption rate and the dose of drug (Fig. 3) . The magnitude of ko is only a small percentage of the maximum velocity, Vm, and therefore does not represent the maximum metabolic rate of the drug. The value of this slope, alone, cannot be used to estimate any of the enzyme parameters. As illustrated by Figs. 4 and 5, the peak drug concentration and the areas under the C,t curves (0-6 hr) are both dependent on the rate of drug absorption and the dose of drug. Although not shown, the relationships of total area (0-oe hr) under the C,t curves to Co and/ca are very similar to those shown in Fig. 5 . Slowing the absorption rate of a drug which is fully absorbed not only decreases the peak drug concentration but also decreases the area under the C,t curve. These phenomena would also be predicted by the one-compartment open model with first-order absorption and Michaelis-Menten elimination, but could not be explained by the classical linear one-or two-compartment open models. Either nonlinear model could help explain the effects of food and stomach emptying on drug blood levels and bioavailability. Even for drugs which are fully absorbed, these models would predict decreases in drug blood concentration and bioavailability when food was administered or stomach emptying was slowed because of a decreased rate of drug absorption. The values listed in Table I demonstrate the effect of using the onecompartment open model (scheme 2) to fit data which were generated using the two-compartment open model (scheme 1). In order to compare the procedure outlined in the Appendix with more commonly used methods, the enzyme constants for one set of data (ka = 8, Co = 2) were also analyzed ... Nonlinear in vivo data have in the past almost exclusively been analyzed using one-compartment analysis. The above simulations illustrate that one-compartment analysis of real data, which "actually" obey the twocompartment model, would yield numbers having very little relationship to those which would be obtained by two-compartment analysis. In vitro enzyme constants are often determined by incubating purified enzyme with substrate in a well-stirred system. Such an in vitro system would be expected to obey the one-compartment open model. Thus enzyme parameters determined from in vitro experiments, by utilizing one-compartment analysis (e.g., Lineweaver-Burk plots), should accurately reflect the in vitro enzyme constants under the particular experimental conditions. Moreover, if 
CONCLUSION
Values of apparent enzyme constants, V,, and K,,, estimated by utilizing one-compartment analysis for drugs which are actually described by the two-compartment open model involving Michaelis-Menten elimination kinetics bear little relationship to the values of these constants applicable to the multicompartmental system. To distinguish a one-compartment from a multicompartmental system, the simulations discussed have indicated that blood levels need be measured after several different doses of a drug. At low doses there may be no "nose" on the blood concentration profile, whereas at higher doses the "nose" becomes prominent (see Figs. 1 and 2 ). Once such a "nose" is seen, the investigator should become aware that the appropriate model most probably is a multicompartmental one. It is this "nose," evident in the alcohol data reported by Wagner and Patel (3), which leads the authors to believe that pharmacokinetics of ethanol in man involves a multicompartmental rather than a one-compartment model. This is being pursued with intravenous studies in man and will be reported at a later date.
APPENDIX
Calculation of the Values of V,. and Km Utilizing the One-Compartment Open Model and Terminal Data Obtained from Computer Simulations of the Two-Compartment Model with Michaelis-Menten Elimination Kinetics
The one-compartment model (scheme 2) is described mathematically by Instead of using the arithmetic midpoint of 6". and C,+1 as the corresponding value of C, it is probably better to use the geometric mean of 6", and C.+ 1.
Hence for points n and n + 1, 
Values of y and x were obtained by using simulated C,t data. Linear regression of y on x gave an apparent straight line whose slope was 1IV. and intercept was Km/V,~. These were solved to obtain estimates of Vm and K,,.
